AMED SCARDA「ワクチン開発のための世界トップレベル研究開発拠点の形成事業」合同シンポジウム

*Peng Gao¹, Reiko Shinkura¹ (1. Institute for Quantitative Biosciences, The University of Tokyo (Japan))

*Yohei Uchida¹, Shingo Umemoto^1,2, Rika Nakahashi^1,3, Hiroshi Kiyono^1,3,4,5,6,7 (1. Department of Human Mucosal Vaccinology, Chiba University Hospital (Japan), 2. Department of Otorhinolaryngology and Head & Neck Surgery, Faculty of Medicine, Oita University (Japan), 3. Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University (Japan), 4. Future Medicine Education and Research Organization, Chiba University (Japan), 5. Department of Medicine, UC San Diego School of Medicine (USA), 6. CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), UC San Diego School of Medicine (USA), 7. Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University (Japan))

*Koshiro Tabata¹, Takeshi Kurosu², Masahiro Nakano², Yukari Itakura¹, Gabriel Gonzalez¹, Shinji Saito¹, Tadaki Suzuki², Hirofumi Sawa¹ (1. IVReD, Hokkaido University (Japan), 2. NIID, Japan Institute for Health Security (Japan))

*Misako Nakayama¹, Tomoya Hayashi¹, Burcu Temizoz¹, Hideo Negishi¹, Noritake Kikunishi², Tetsukan Woo², Ken J Ishii¹ (1. Institute of Medical Science, Department of Infection and Microbiology, Division of Vaccine Science (Japan), 2. Department of General Thoracic Surgery, Yokohama City University Medical Center Hospital, Yokohama (Japan))

*Shara Bakytbek^1,2,3, Farzaneh Valanezhad^1,2,3, Ayako Hyuga^1,2,3, Shin-Ichi Inoue^2,4, Yui Katsuyuki⁵, Shusaku Mizukami^3,6, Risa Nakamura^1,2,3, Haruka Abe⁷, Futoshi Hasebe^2,7, Kazuhide Onoguchi⁸, Sebastian Kapell^9,10, Kouichi Morita^3,11, Shinjiro Hamano^1,2,3 (1. Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki (Japan), 3. The Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University, Nagasaki (Japan), 4. Department of Molecular Microbiology and Immunology, Division of Immunology, Nagasaki University, Nagasaki (Japan), 5. SHIONOGI Global Infectious Diseases Division Institute of Tropical Medicine, Nagasaki University, Nagasaki (Japan), 6. Department of Immune Regulations, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 7. Vietnam Research Station, center for Infectious Disease Research in Asia and Africa, Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan), 8. AI Drug Development Division, NEC Corporation, Tokyo (Japan), 9. Department of Vaccine Informatics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 10. NEC OncoImmunity AS, Ullernchausseen 64/66, 0379, Oslo (Norway), 11. Department of Virology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki Department of Virology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan))

*Saya Hisano^1,3, Akari Suzuki¹, Akiko Oguchi^1,4, Rintaro Fujimoto^1,2,3, Hiroki Kitaoka^1,2, Raku Son^1,4, Ryuya Edahiro^1,3, Go Sato^1,2, Yoshihiko Tomofuji^1,2, Yasuhiro Murakawa^1,4, Yukinori Okada^1,2,3, Kazuhiko Yamamoto¹ (1. RIKEN Center for Integrative Medical Sciences (Japan), 2. The University of Tokyo (Japan), 3. The University of Osaka (Japan), 4. Kyoto University (Japan))

*Yuji Yamamoto^1,2, Yuya Shirai^1,2,3,4, Kyuto Sonehara^1,4,5, Shinichi Namba^1,4,5, Takafumi Ojima^1,4,5,6, Kenichi Yamamoto^1,7, Ryuya Edahiro^1,2,4, Ken Suzuki^1,8, Akinori Kanai⁹, Yoshiya Oda¹⁰, Yutaka Suzuki⁹, Takayuki Morisaki¹¹, Akira Narita⁶, Yoshito Takeda², Gen Tamiya⁶, Masayuki Yamamoto⁶, Koichi Matsuda¹¹, Atsushi Kumanogoh², Toshimasa Yamauchi⁸, Takashi Kadowaki^8,12, Yukinori Okada^1,3,4,5 (1. Department of Statistical Genetics, Graduate School of Medicine, The University of Osaka (Japan), 2. Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka (Japan), 3. Laboratory of Statistical Immunology, Immunology Frontier Research Center (WPI-IFReC), The University of Osaka (Japan), 4. Laboratory for Systems Genetics, RIKEN Center for Integrative Medical Sciences (Japan), 5. Department of Genome Informatics, Graduate School of Medicine, The University of Tokyo (Japan), 6. Tohoku Medical Megabank Organization, Tohoku University (Japan), 7. Department of Pediatrics, Graduate School of Medicine, The University of Osaka (Japan), 8. Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo (Japan), 9. Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo (Japan), 10. Department of Lipidomics, Graduate School of Medicine, The University of Tokyo (Japan), 11. Laboratory of Clinical Genome Sequencing, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo (Japan), 12. Toranomon Hospital (Japan))

*Ryuya Edahiro^1,2, Go Sato^1,2,3, Yuya Shirai^1,2, Ryunosuke Saiki⁴, Shuhei Sakakibara¹, Seishi Ogawa⁴, Atsushi Kumanogoh¹, Yukinori Okada^1,2,3 (1. Graduate School of Medicine, The University of Osaka (Japan), 2. RIKEN Center for Integrative Medical Sciences (Japan), 3. Graduate School of Medicine, The University of Tokyo (Japan), 4. Kyoto University (Japan))

*Rintaro Fujimoto^1,2,3, Hiroki Kitaoka^1,2, Saya Hisano^1,3, Ryuya Edahiro^1,3, Go Sato^1,2,3, Yoshihiko Tomofuji^1,2, Akari Suzuki¹, Yukinori Okada^1,2,3, Kazuhiko Yamamoto¹ (1. RIKEN Center for Integrative Medical Sciences (Japan), 2. The University of Tokyo (Japan), 3. The University of Osaka (Japan))

*Shinichi Namba^1,2,3, Kyuto Sonehara^1,2,3, Yuriko N Koyanagi⁴, Takezo Kikuchi¹, Takafumi Ojima^2,3,5, Ryuya Edahiro^2,3, Go Sato^1,2,3, Taiki Yamaji⁶, Hiroyuki Ueda², Kenichi Yamamoto², Akinori Kanai¹, Shinichi Higashiue⁷, Shuzo Kobayashi⁷, Hiroki Yamaguchi⁸, Yasunobu Nagata⁸, Yasushi Okazaki⁹, Naoyuki Matsumoto⁹, Kenta Motomura¹⁰, Hidenobu Koga¹⁰, Asahi Hishida¹¹, Hiroaki Ikezaki¹², Megumi Hara¹³, Mako Nagayoshi¹⁴, Isao Oze⁴, Shiori Nakano⁶, Yoshiya Oda¹, Yutaka Suzuki¹, Motoki Iwasaki⁶, Norie Sawada⁶, Keitaro Matsuo⁴, Takayuki Morisaki¹, Toshimasa Yamauchi¹, Takashi Kadowaki¹⁵, Koichi Matsuda¹, Yukinori Okada^1,2,3 (1. The University of Tokyo (Japan), 2. The University of Osaka (Japan), 3. RIKEN Center for Integrative Medical Sciences (Japan), 4. Aichi Cancer Center (Japan), 5. Tohoku University (Japan), 6. National Cancer Center (Japan), 7. Tokushukai Group (Japan), 8. Nippon Medical School (Japan), 9. Juntendo University (Japan), 10. Iizuka Hospital (Japan), 11. Aichi Medical University (Japan), 12. Kyushu University (Japan), 13. Saga University (Japan), 14. Nagoya University (Japan), 15. Toranomon Hospital (Japan))

*Seitaro Nomura¹ (1. The University of Tokyo Hospital (Japan))

*Sho Ohta¹, Yasuhiro Yamada¹ (1. Graduate School of Medicine, The University of Tokyo (Japan))

*Masatsugu Ema¹, Toshifumi Morimura¹, Yasushi Itoh², Shoma Matsumoto¹ (1. RCALS, Shiga University of Medical Science (Japan), 2. Dept. of Pathology (Japan))

*Hiroshi Suemizu¹, Yuichiro Higuchi¹, Shotaro Uehara¹, Nao Yoneda¹, Kazutoshi Murai², Masao Honda² (1. Central Institute for Experimental Medicine and Life Science (Japan), 2. Kanazawa University Graduate School of Medical Science (Japan))

*Maya Shofa¹, Emiko Urano¹, Akatsuki Saito², Yasuhiro Yasutomi¹ (1. Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN) (Japan), 2. Department of Veterinary Medicine, Faculty of Agriculture, University of Miyazaki, Miyazaki, Miyazaki (Japan))

*JUNETSU IGARASHI¹, Kimiyo Kamamoto-Shono¹, Yoshihiro Takashima¹, Takayuki Yoshioka¹ (1. CAMaD, The University of Osaka (Japan))

*JINJUE LIANG¹, Takuma Shibata¹, Emi Nishimura¹, Kosuke Takeshima², Yasushi Kawaguchi² (1. Division of aging and regeneration,The University of Tokyo (Japan), 2. Division of Molecular Virology,The University of Tokyo (Japan))

*Katsuhiko Horibe¹ (1. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (Japan))

*Yosuke Isobe¹, Hiroshi Tsugawa¹, Makoto Arita¹ (1. RIKEN Center for Integrative Medical Sciences (Japan))

*Yuji Watanabe¹, Hideki Toya², Yuka Masshardt³, Yuriko Kano⁴, Hiroshi Mizuuchi¹ (1. Chiba University, Synergy Institute for Futuristic Mucosal Vaccine Research and Development (Japan), 2. Public Relations Office, Chiba University (Japan), 3. Academic Research & Innovation Management Organization, Chiba University (Japan), 4. Chiba University Hospital (Japan))

*Shunsuke Kita¹, Souta Kobayashi¹, Toshiki Sekiya¹, Naoki Nomura¹, Chimuka Handabile¹, Shingai Masashi¹, Hiroshi Kida¹, Katsumi Maenaka¹ (1. IVReD, Hokkaido University (Japan))

*Katsumi Maenaka¹ (1. Faculty of Pharamaceutical Siences, Hokkaido University (Japan))

*Junna Kawasaki^1,2,3, Jumpei Ito^4,5, Michiaki Hamada², Tadaki Suzuki^1,3 (1. Department of Infectious Disease Pathobiology, Graduate School of Medicine, Chiba University (Japan), 2. Faculty of Science and Engineering, Waseda University, Tokyo (Japan), 3. Department of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo (Japan), 4. Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (Japan), 5. International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo (Japan))

Jessica Severin¹, Shohei Asami¹, Hiroaki Hatano¹, Tamotsu Kato¹, Takahiro Nishino¹, Koshi Imami¹, Kazuyoshi Ishigaki¹, Yukinori Okada¹, Akari Suzuki¹, Kazuhiko Yamamoto¹, *Takeya Kasukawa¹ (1. RIKEN Center for Integrative Medical Sciences (Japan))

*Hitomi Nakamura¹, Miwako Iwai¹, Tomoki Todo¹ (1. Division of Innovative Cancer Therapy, The Institute of Medical Science, The University of Tokyo (Japan))

*菅野 芳明¹
*Yoshiaki Kanno¹, Aya Ishizaka¹, Iwao Kukimoto², Michiko Koga^1,3 (1. Division of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, The University of Tokyo (Japan), 2. Center for Pathogen Genomics, Japan Institute for Health Security (Japan), 3. The UTOPIA Center, The University of Tokyo (Japan))

*Wataru Sekine¹, Natsuki Otani², Hiroho Ishida³, Erika Hujimoto², Yuji Nakamura², Kosuke Ohira¹, Kaixin Li¹, Misa Katayama¹, Ayano Ichikawa¹, Yuta Wakabayashi¹, Akiko Uema¹, Tadaki Suzuki⁴, Shin Murakami¹, Sho Miyamoto⁴, Taisuke Horimoto¹ (1. Department of Veterinary Medical Science, The University of Tokyo (Japan), 2. Chiba Prefectural Agricultural Mutual Aid Association (Japan), 3. Laboratory of Infectious Diseases, Azabu University (Japan), 4. Laboratory of Infectious Disease Pathobiology, Chiba University (Japan))

Rina Sakuno¹, *Farahana Kresno Dewayanti¹, Tsubasa Nishi¹, Shiroh Iwanaga¹ (1. The University of Osaka (Japan))

Shinya Miyazaki^1,2, Akiko Baba^1,2, Vegard Børve Sørdal³, Huai Chuang^1,2, Lluis Artus Suarez³, Matheus Ferraz³, Ioannis Vardaxis³, Agnieszka Gromadka³, Shusaku Mizukami^1,4, Sebastian Kapell^1,5, Kaidre Bendjama³, Kazuhide Onoguchi⁶, *Osamu Kaneko^1,2 (1. Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance, Nagasaki Univ. (Japan), 2. Department of Protozoology, Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan), 3. NEC Oncoimmunity AS (Norway), 4. Department of Immune Regulation, Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan), 5. Department of Vaccine Informatics, Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan), 6. NEC Corporation (Japan))

*Ryo Matsunaga¹, Tomomi Aoki¹, Kouhei Tsumoto^1,2 (1. School of Engineering, The University of Tokyo (Japan), 2. Institute of Medical Science, the University of Tokyo (Japan))

Masakaze Hamada¹, Junna Kawasaki², Naoko Fujita¹, Ryo Komorizono¹, Mie Kobayashi-Ishihara¹, Takahiro Tabuchi³, *Yuki Furuse¹ (1. UTOPIA, University of Tokyo (Japan), 2. cSIMVa, Chiba University (Japan), 3. Tohoku University (Japan))

*Koji Hashimoto¹ (1. Graduate School of Arts and Sciences, The University of Tokyo (Japan))

*Yaeko Nakajima -Takagi¹, Takanori Fukuta¹, Atsushi Iwama¹ (1. Institute of Medical Science, The University of Tokyo (Japan))

*Satoshi Hashimoto¹, Jennifer SAUERLAND², Jiahuan ZENG¹, Chisato Kikuguchi¹, Toshifumi INADA¹ (1. Division of RNA and Gene Regulation The Institute of Medical Science, The University of Tokyo (Japan), 2. University of Munich LMU (Germany))

*Saki Inai¹, Shinji C. Nagasaki², Tomonori D. Fukuda¹, Ikumi Nagano¹, Mayumi Yamada⁴, Itaru Imayoshi^1,2,3 (1. Laboratory of Brain Development and Regeneration, Division of Systemic Life Science, Kyoto University Graduate School of Biostudies (Japan), 2. Center for Living Systems Information Science, Kyoto University Graduate School of Biostudies (Japan), 3. Laboratory of Deconstruction of Stem Cells, Institute for Life and Medical Sciences, Kyoto University (Japan), 4. Laboratory of Cell Biology, Institute for Life and Medical Sciences, Kyoto University (Japan))

*Sarunporn Tandhavanant^1,2, Hirotaka Hiyoshi¹, Toshio Kodama¹ (1. Department of Bacteriology, Institute of Tropical Medicine, Nagasaki University (Japan), 2. Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University (Thailand))